GOLDENWELL BIOTECH, INC.

GOLDENWELL BIOTECH, INC. was incorporated on August 20, 2019, and operates with a fiscal year end of December 31. The company has no subsidiaries. Its business offices are located at 581 Boston Mills Road, Suite 300, Hudson, Ohio 44236, though it does not conduct operations at this location, only receiving mail. As of December 31, 2024, GOLDENWELL BIOTECH, INC. reported Cash and Cash Equivalents of $49,404, Total Assets of $224,192, Total Liabilities of $271,433, and Total Stockholders' Equity of $(47,241). The company's business relies on exclusive patent license agreements. Effective July 20, 2020, GOLDENWELL BIOTECH, INC. entered into an Exclusive License Agreement with Australian Trefoil Health Technologies Pty Ltd. Under this agreement, the company licensed technology and packaging designs for its Sugar Master and DNA Repair products, as well as other products. This license covers all territories worldwide, excluding China, and is valid until November 15, 2025, for a consideration of $10.00. Australian Trefoil Health Technologies Pty Ltd is controlled by Li Yang, a director of GOLDENWELL BIOTECH, INC. Additionally, effective July 20, 2020, the company entered into an Exclusive License Agreement with Ji Lin JZY Biotech Inc. This agreement grants GOLDENWELL BIOTECH, INC. a license for the technology it uses in its products. This license also covers all territories worldwide, excluding China, and is valid until January 11, 2035, for a consideration of $10.00. Ji Lin JZY Biotech Inc. is controlled by Shang Liu, the company's President, Chief Executive Officer, and a director.